BDBM293985 (2S)-4-(4-(5-((4-(1-(1H- Tetrazol-5-yl)pent-3-yn-2- yl)phenoxy)methyl)benzo[b] thiophen-3-yl)-3- methylphenyl)tetrahydro-2H- thiopyran 1,1-dioxide::US10106553, Compound 17

SMILES CC#C[C@@H](Cc1nnn[nH]1)c1ccc(OCc2ccc3scc(-c4ccc(cc4C)C4CCS(=O)(=O)CC4)c3c2)cc1

InChI Key

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 293985   

TargetFree fatty acid receptor 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM293985((2S)-4-(4-(5-((4-(1-(1H- Tetrazol-5-yl)pent-3-yn-2...)
Affinity DataEC50:  97nMT: 25°CAssay Description:Compounds were tested in a calcium flux assay using transfected HEK293 cells stably expressing either human GPR40 or rat GPR40. Human GPR40 expressin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent